Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Pain Pract ; 23(8): 974-977, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37083017

ABSTRACT

INTRODUCTION: Spinal cord stimulation is an important therapy option for the treatment of chronic neuropathic pain of spinal or peripheral etiology. As with any implantable device, complications may arise. These must be promptly identified and managed to maintain patients in successful therapy. CASE REPORT: We report an unusual case of cephalad and extraspinal lead migration requiring surgical intervention in order to salvage therapy. CONCLUSION: Lead migration is one of the most common complications of spinal cord stimulation, and left untreated can lead to loss of therapy and possible device explant. A strategy for correcting this issue is needed, and we present an unusual case to consider when faced with a loss of therapy from lead migration.


Subject(s)
Neuralgia , Spinal Cord Stimulation , Humans , Spinal Cord Stimulation/adverse effects , Electrodes, Implanted/adverse effects , Neuralgia/etiology , Neuralgia/therapy , Spinal Cord
2.
Cell Rep ; 18(8): 1858-1868, 2017 02 21.
Article in English | MEDLINE | ID: mdl-28228253

ABSTRACT

Cancer stem cells (CSCs) have high tumorigenic capacity. Here, we show that stem-like traits of specific human cancer cells are reduced by overexpression of the histone deacetylase sirtuin 6 (SIRT6). SIRT6-sensitive cancer cells bear mutations that activate phosphatidylinositol-3-kinase (PI3K) signaling, and overexpression of SIRT6 reduces growth, progression, and grade of breast cancer in a mouse model with PI3K activation. Tumor metabolomic and transcriptomic analyses reveal that SIRT6 overexpression dampens PI3K signaling and stem-like characteristics and causes metabolic rearrangements in this cancer model. Ablation of a PI3K activating mutation in otherwise isogenic cancer cells is sufficient to convert SIRT6-sensitive into SIRT6-insensitive cells. SIRT6 overexpression suppresses PI3K signaling at the transcriptional level and antagonizes tumor sphere formation independent of its histone deacetylase activity. Our data identify SIRT6 as a putative molecular target that hinders stemness of tumors with PI3K activation.


Subject(s)
Neoplasms/metabolism , Neoplastic Stem Cells/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Sirtuins/metabolism , Acetylation , Animals , Carcinogenesis/metabolism , Cell Line, Tumor , Cell Proliferation/physiology , Humans , Mice , Mice, Inbred NOD , Mice, SCID , Mutation/physiology , Signal Transduction/physiology , Transcription, Genetic/physiology
3.
Mol Metab ; 4(11): 846-56, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26629408

ABSTRACT

OBJECTIVE: Available treatment for obesity and type 2 diabetes mellitus (T2DM) is suboptimal. Thus, identifying novel molecular target(s) exerting protective effects against these metabolic imbalances is of enormous medical significance. Sirt6 loss- and gain-of-function studies have generated confounding data regarding the role of this sirtuin on energy and glucose homeostasis, leaving unclear whether activation or inhibition of SIRT6 may be beneficial for the treatment of obesity and/or T2DM. METHODS: To address these issues, we developed and studied a novel mouse model designed to produce eutopic and physiological overexpression of SIRT6 (Sirt6BAC mice). These mutants and their controls underwent several metabolic analyses. These include whole-blood reverse phase high-performance liquid chromatography assay, glucose and pyruvate tolerance tests, hyperinsulinemic-euglycemic clamp assays, and assessment of basal and insulin-induced level of phosphorylated AKT (p-AKT)/AKT in gastrocnemius muscle. RESULTS: Sirt6BAC mice physiologically overexpress functionally competent SIRT6 protein. While Sirt6BAC mice have normal body weight and adiposity, they are protected from developing high-caloric-diet (HCD)-induced hyperglycemia and glucose intolerance. Also, Sirt6BAC mice display increased circulating level of the polyamine spermidine. The ability of insulin to suppress endogenous glucose production was significantly enhanced in Sirt6BAC mice compared to wild-type controls. Insulin-stimulated glucose uptake was increased in Sirt6BAC mice in both gastrocnemius and soleus muscle, but not in brain, interscapular brown adipose, or epididymal adipose tissue. Insulin-induced p-AKT/AKT ratio was increased in gastrocnemius muscle of Sirt6BAC mice compared to wild-type controls. CONCLUSIONS: Our data indicate that moderate, physiological overexpression of SIRT6 enhances insulin sensitivity in skeletal muscle and liver, engendering protective actions against diet-induced T2DM. Hence, the present study provides support for the anti-T2DM effect of SIRT6 and suggests SIRT6 as a putative molecular target for anti-T2DM treatment.

4.
J Neurosci ; 30(44): 14630-4, 2010 Nov 03.
Article in English | MEDLINE | ID: mdl-21048120

ABSTRACT

D-Fenfluramine (D-Fen) increases serotonin (5-HT) content in the synaptic cleft and exerts anorexigenic effects in animals and humans. However, the neural circuits that mediate these effects are not fully identified. To address this issue, we assessed the efficacy of D-Fen-induced hypophagia in mouse models with manipulations of several genes in selective populations of neurons. Expectedly, we found that global deletion of 5-HT 2C receptors (5-HT(2C)Rs) significantly attenuated D-Fen-induced anorexia. These anorexigenic effects were restored in mice with 5-HT(2C)Rs expressed only in pro-opiomelanocortin (POMC) neurons. Further, we found that deletion of melanocortin 4 receptors (MC4Rs), a downstream target of POMC neurons, abolished anorexigenic effects of D-Fen. Reexpression of MC4Rs only in SIM1 neurons in the hypothalamic paraventricular nucleus and neurons in the amygdala was sufficient to restore the hypophagic property of D-Fen. Thus, our results identify a neurochemically defined neural circuit through which D-Fen influences appetite and thereby indicate that this 5-HT(2C)R/POMC-MC4R/SIM1 circuit may yield a more refined target to exploit for weight loss.


Subject(s)
Anorexia/metabolism , Anorexia/physiopathology , Fenfluramine/pharmacology , Melanocortins/physiology , Serotonin/physiology , Animals , Anorexia/chemically induced , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Neural Pathways/cytology , Neural Pathways/drug effects , Neural Pathways/metabolism , Pro-Opiomelanocortin/physiology , Receptor, Melanocortin, Type 4/deficiency , Receptor, Melanocortin, Type 4/genetics , Receptor, Serotonin, 5-HT2C/deficiency , Receptor, Serotonin, 5-HT2C/genetics , Serotonin/metabolism , Selective Serotonin Reuptake Inhibitors/pharmacology , Weight Loss/genetics , Weight Loss/physiology
5.
Pain Med ; 11(9): 1328-34, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20667021

ABSTRACT

OBJECTIVE: To assess the efficacy of fluoroscopically guided, contrast-enhanced lumbar interlaminar epidural steroid injections (IL-ESI) for lower limb pain greater than axial low back pain using self-reported pain scores. STUDY DESIGN: Prospective, single-arm, pilot, observational human study. SETTING: An outpatient private practice interventional spine specialty referral center. DATA/RESULTS: Twenty-one patients were initially included in analysis. Thirteen patients had "complete data" and completed 3 months of data after their most recent IL-ESI. Their self-reported 3-day average Numeric Pain Rating Scale (NPRS) score (0 to 10) at inception, 2 weeks, 6 weeks, and 3 months were 6.38, 3.00, 2.88, and 3.04, respectively. The average NPRS score at 3 months was significantly lower than at inception after the IL-ESI for this group (P = 0.0001, 95% confidence interval [1.69, 5.00]). Eight patients had "incomplete data." Their self-reported 3-day average NPRS scores at inception, 2 weeks, and 6 weeks were 6.69, 4.25, and 4.00, respectively. Of the eight patients who had incomplete data, two patients had surgical intervention, five patients had lumbar transforaminal epidural steroid injections, and one patient was unable to be contacted after 6 weeks. DISCUSSION/CONCLUSION: This prospective, single-arm pilot study demonstrates that subjects who have had fluoroscopically guided, contrast-enhanced lumbar IL-ESIs for radicular > axial pain can have improved (lowered) NPRS for at least 3 months. It would be worthwhile to pursue a more rigorous study.


Subject(s)
Fluoroscopy/methods , Injections, Epidural/methods , Low Back Pain/drug therapy , Lumbosacral Region , Radiculopathy/drug therapy , Steroids/administration & dosage , Steroids/therapeutic use , Adult , Aged , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/therapeutic use , Female , Glucocorticoids/administration & dosage , Glucocorticoids/therapeutic use , Humans , Male , Middle Aged , Pilot Projects , Prospective Studies , Treatment Outcome , Triamcinolone/administration & dosage , Triamcinolone/therapeutic use
6.
Regul Pept ; 155(1-3): 91-8, 2009 Jun 05.
Article in English | MEDLINE | ID: mdl-19361544

ABSTRACT

Ghrelin is a hormone that influences many physiological processes and behaviors, such as food intake, insulin and growth hormone release, and a coordinated response to chronic stress. However, little is known about the molecular pathways governing ghrelin release and ghrelin cell function. To better study ghrelin cell physiology, we have generated several transgenic mouse lines expressing humanized Renilla reniformis green fluorescent protein (hrGFP) under the control of the mouse ghrelin promoter. hrGFP expression was especially abundant in the gastric oxyntic mucosa, in a pattern mirroring that of ghrelin immunoreactivity and ghrelin mRNA. hrGFP expression also was observed in the duodenum, but not in the brain, pancreatic islet, or testis. In addition, we used fluorescent activated cell sorting (FACS) to collect and partially characterize highly enriched populations of gastric ghrelin cells. We suggest that these novel ghrelin-hrGFP transgenic mice will serve as useful tools to better understand ghrelin cell physiology.


Subject(s)
Ghrelin/metabolism , Animals , Brain/metabolism , Duodenum/metabolism , Flow Cytometry , Gastric Mucosa/metabolism , Ghrelin/blood , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Immunohistochemistry , In Situ Hybridization , Islets of Langerhans/metabolism , Male , Mice , Mice, Transgenic , Microscopy, Fluorescence , Promoter Regions, Genetic , Reverse Transcriptase Polymerase Chain Reaction , Testis/metabolism
7.
Neuron ; 60(4): 582-9, 2008 Nov 26.
Article in English | MEDLINE | ID: mdl-19038216

ABSTRACT

Drugs activating 5-hydroxytryptamine 2C receptors (5-HT2CRs) potently suppress appetite, but the underlying mechanisms for these effects are not fully understood. To tackle this issue, we generated mice with global 5-HT2CR deficiency (2C null) and mice with 5-HT2CRs re-expression only in pro-opiomelanocortin (POMC) neurons (2C/POMC mice). We show that 2C null mice predictably developed hyperphagia, hyperactivity, and obesity and showed attenuated responses to anorexigenic 5-HT drugs. Remarkably, all these deficiencies were normalized in 2C/POMC mice. These results demonstrate that 5-HT2CR expression solely in POMC neurons is sufficient to mediate effects of serotoninergic compounds on food intake. The findings also highlight the physiological relevance of the 5-HT2CR-melanocortin circuitry in the long-term regulation of energy balance.


Subject(s)
Energy Metabolism/genetics , Homeostasis/genetics , Hypothalamus/metabolism , Pro-Opiomelanocortin/metabolism , Receptor, Serotonin, 5-HT2C/genetics , Serotonin/metabolism , Animals , Appetite/drug effects , Appetite/genetics , Appetite Depressants/pharmacology , Appetite Regulation/genetics , Drug Resistance/genetics , Hyperphagia/genetics , Hyperphagia/metabolism , Hyperphagia/physiopathology , Hypothalamus/cytology , Mice , Mice, Knockout , Motor Activity/genetics , Neural Pathways/cytology , Neural Pathways/metabolism , Obesity/genetics , Obesity/metabolism , Obesity/physiopathology
8.
Nat Neurosci ; 11(7): 752-3, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18552842

ABSTRACT

We found that increasing ghrelin levels, through subcutaneous injections or calorie restriction, produced anxiolytic- and antidepressant-like responses in the elevated plus maze and forced swim test. Moreover, chronic social defeat stress, a rodent model of depression, persistently increased ghrelin levels, whereas growth hormone secretagogue receptor (Ghsr) null mice showed increased deleterious effects of chronic defeat. Together, these findings demonstrate a previously unknown function for ghrelin in defending against depressive-like symptoms of chronic stress.


Subject(s)
Depression/prevention & control , Ghrelin/administration & dosage , Stress, Psychological/complications , Analysis of Variance , Animals , Behavior, Animal , Caloric Restriction/methods , Depression/etiology , Disease Models, Animal , Eating/drug effects , Eating/genetics , Enzyme-Linked Immunosorbent Assay , Freezing Reaction, Cataleptic/drug effects , Freezing Reaction, Cataleptic/physiology , Ghrelin/metabolism , Maze Learning/physiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Motor Activity/drug effects , Motor Activity/genetics , Orexin Receptors , Reaction Time/physiology , Receptors, G-Protein-Coupled/deficiency , Receptors, Ghrelin/deficiency , Receptors, Neuropeptide/deficiency , Stress, Psychological/genetics , Swimming , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...